Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): A double-blind, randomised, placebo-controlled, phase 2 trial
- TESDAD study group
Research output: Contribution to journal › Article › peer-review
239
Link opens in a new tab
Scopus
citations